Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 45: 732-738, 1999;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (20)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Holtzman, N. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Holtzman, N. A.
Related Collections
Right arrow Molecular Diagnostics and Genetics
Right arrow Laboratory Management
Right arrow Evidence Based Laboratory Medicine and Test Utilization
Right arrow Clinical Chemistry Forum
Right arrow Hemostasis and Thrombosis
Right arrow Proteomics and Protein Markers
Right arrow Hematology
Right arrow Endocrinology and Metabolism
(Clinical Chemistry. 1999;45:732-738.)
© 1999 American Association for Clinical Chemistry, Inc.


Clinical Chemistry Forum

Promoting Safe and Effective Genetic Tests in the United States: Work of the Task Force on Genetic Testing

Neil A. Holtzman
The Task Force on Genetic Testing was created to review genetic testing in the United States and, when necessary, to make recommendations to ensure the development of safe and effective genetic tests. A survey to explore the state of genetic testing was undertaken for the Task Force and completed in early 1995. The survey, as well as literature reports and other information collected for the Task Force, showed problems affecting safety and effectiveness, as defined by the Task Force: validity and utility of predictive tests, laboratory quality, and appropriate use by healthcare providers and consumers. On the basis of these findings, the Task Force made several recommendations to ensure safe and effective genetic testing. The Secretary of Health and Human Services followed up one recommendation by creating the Secretary's Advisory Committee on Genetic Testing. One of its functions will be to implement other recommendations of the Task Force.© 1999 American Association for Clinical Chemistry




The following articles in journals at HighWire Press have cited this article:


Home page
Human RelationsHome page
L. A. Barclay and K. S. Markel
Discrimination and stigmatization in work organizations: A multiple level framework for research on genetic testing
Human Relations, June 1, 2007; 60(6): 953 - 980.
[Abstract] [PDF]


Home page
Clin. Cancer Res.Home page
H. H. Ezzeldin and R. B. Diasio
Genetic testing in cancer therapeutics.
Clin. Cancer Res., July 15, 2006; 12(14): 4137 - 4141.
[Full Text] [PDF]


Home page
JAMAHome page
S. E. Waisbren, S. Albers, S. Amato, M. Ampola, T. G. Brewster, L. Demmer, R. B. Eaton, R. Greenstein, M. Korson, C. Larson, et al.
Effect of Expanded Newborn Screening for Biochemical Genetic Disorders on Child Outcomes and Parental Stress
JAMA, November 19, 2003; 290(19): 2564 - 2572.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
T. O. Keku, T. Rakhra-Burris, and R. Millikan
Gene Testing: What the Health Professional Needs to Know
J. Nutr., November 1, 2003; 133(11): 3754S - 3757.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
D. S. Young and D. G.B. Leonard
Issues in Genetic Testing
Clin. Chem., June 1, 1999; 45(6): 915 - 926.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
D. S. Young
Issues in Genetic Testing
Clin. Chem., May 1, 1999; 45(5): 725 - 725.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the American Association for Clinical Chemistry.